Key result
Hydroxychloroquine with or without azithromycin shows no clear effect on QT intervals in severe COVID-19.
Answers are grounded in this paper and cite their sources.
Supports QT monitoring with hydroxychloroquine in critically ill COVID-19; leaves open arrhythmia risk in other populations.
This case series assesses QT intervals for French patients with coronavirus disease 2019 (COVID-19) treated with hydroxychloroquine alone or in combination with azithromycin.
No takes yet. Share an insight, caveat, or question.
Bessière et al. (2020) studied this question. Hydroxychloroquine alone or combined with azithromycin was evaluated for its effect on QT intervals in critically ill French patients with COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: